Curium Pharma has 6 close competitors: Course Hero, Attentive, Carbon Health.
Sector, valuation and status for each competitor.
A private valuation and a public market cap share one column; each row names its basis and date.
Curium Pharma
Course Hero
Attentive
Carbon Health
Certik
Chainguard
CollibraPharmaceutical company focused on specialty pharmaceuticals and drug development
Curium Pharma competes with 6 companies here: Course Hero, Attentive, Carbon Health, Certik, Chainguard, Collibra.
Curium Pharma was last valued at $7B . That price was agreed in one transaction and holds until the next round. A listed competitor is repriced every trading session.
The last valuation is $7B.
Lead investors for each round are in the funding timeline.
The routes section explains what is realistically available for a company at this stage.
No. Curium Pharma is a private company; its shares do not trade on a public exchange.
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
